BB Biotech AG
Company Information

Vordergasse 3
Schaffhausen, Schaffhausen, 8200 Switzerland

BB Biotech AG Rankings


Top 3 Competitors

Unlock access to over 100 million contacts! Starting at only $50 per user/month*

  • Up-to-the moment intelligence helps you set strategy, prepare for sales calls, and close business.
  • Easy-to-read reports on over 85 million companies and 900 industries build your understanding of the companies you work with.
  • Reports are written by real industry experts. Their summaries save you hours of research.

Unlock a Hoover's Basic Subscription.
To talk to a Business Information Consultant please call (866) 473-3932

*Prices reflect per user/per month cost based on an annual subscription for a minimum of 5 users.


BB Biotech AG Company Profile

BB BIOTECH banks on genetics. The investment firm funds private and public biotechnology companies worldwide. BB BIOTECH's portfolio includes significant stakes in about five companies including Actelion, Isis Pharmaceuticals, and Celgene. The company rounds out its portfolio with smaller stakes in another five firms, keeping its holdings below 5%. BB BIOTECH prefers to invest in well-managed small- to mid-sized companies that are within two years of bringing a product to market. It focuses on listed companies. The company has some CHF 2 billion (nearly $2.1 billion) under management. Founded in 1993, BB BIOTECH was an early investor in Amgen, one of the world's biggest biotechnology companies.